In NSCLC, common mutation loci include EGFR [94], allogeneic lymphoma kinase (ALK) [95], mesenchymal-epithelial transition factor (MET) [96], and Kirsten rat sarcoma (KRAS) [97]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.